[TENAGA] QoQ TTM Result on 30-Nov-2010 [#1]

Announcement Date
19-Jan-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Aug-2011
Quarter
30-Nov-2010 [#1]
Profit Trend
QoQ- 0.3%
YoY- 31.56%
Quarter Report
View:
Show?
TTM Result
31/08/11 31/05/11 28/02/11 30/11/10 31/08/10 31/05/10 28/02/10 CAGR
Revenue 32,241,200 31,156,900 30,896,000 30,913,800 30,520,900 29,913,300 29,191,800 6.82%
PBT 992,600 2,190,500 3,726,200 4,252,200 4,222,900 3,782,300 3,735,800 -58.57%
Tax -152,400 -472,000 -700,300 -867,100 -858,800 -840,600 -897,600 -69.23%
NP 840,200 1,718,500 3,025,900 3,385,100 3,364,100 2,941,700 2,838,200 -55.48%
-
NP to SH 839,800 1,733,600 3,019,900 3,378,900 3,368,700 2,977,800 2,893,800 -56.06%
-
Tax Rate 15.35% 21.55% 18.79% 20.39% 20.34% 22.22% 24.03% -
Total Cost 31,401,000 29,438,400 27,870,100 27,528,700 27,156,800 26,971,600 26,353,600 12.35%
-
Net Worth 30,138,307 28,994,361 22,193,662 26,113,554 26,067,115 28,304,609 27,404,042 6.52%
Dividend
31/08/11 31/05/11 28/02/11 30/11/10 31/08/10 31/05/10 28/02/10 CAGR
Div 199,742 1,068,646 1,068,646 1,129,233 1,129,233 826,926 826,926 -61.11%
Div Payout % 23.78% 61.64% 35.39% 33.42% 33.52% 27.77% 28.58% -
Equity
31/08/11 31/05/11 28/02/11 30/11/10 31/08/10 31/05/10 28/02/10 CAGR
Net Worth 30,138,307 28,994,361 22,193,662 26,113,554 26,067,115 28,304,609 27,404,042 6.52%
NOSH 5,448,979 5,448,019 4,438,732 4,352,259 4,344,519 4,339,866 4,338,828 16.35%
Ratio Analysis
31/08/11 31/05/11 28/02/11 30/11/10 31/08/10 31/05/10 28/02/10 CAGR
NP Margin 2.61% 5.52% 9.79% 10.95% 11.02% 9.83% 9.72% -
ROE 2.79% 5.98% 13.61% 12.94% 12.92% 10.52% 10.56% -
Per Share
31/08/11 31/05/11 28/02/11 30/11/10 31/08/10 31/05/10 28/02/10 CAGR
RPS 591.69 571.89 696.05 710.29 702.52 689.27 672.80 -8.18%
EPS 15.41 31.82 68.04 77.64 77.54 68.62 66.70 -62.24%
DPS 3.67 19.62 24.08 26.00 26.00 19.07 19.07 -66.56%
NAPS 5.531 5.322 5.00 6.00 6.00 6.522 6.316 -8.44%
Adjusted Per Share Value based on latest NOSH - 4,352,259
31/08/11 31/05/11 28/02/11 30/11/10 31/08/10 31/05/10 28/02/10 CAGR
RPS 554.64 535.99 531.50 531.81 525.05 514.60 502.19 6.82%
EPS 14.45 29.82 51.95 58.13 57.95 51.23 49.78 -56.06%
DPS 3.44 18.38 18.38 19.43 19.43 14.23 14.23 -61.09%
NAPS 5.1847 4.9879 3.818 4.4923 4.4843 4.8692 4.7143 6.52%
Price Multiplier on Financial Quarter End Date
31/08/11 31/05/11 28/02/11 30/11/10 31/08/10 31/05/10 28/02/10 CAGR
Date 29/08/11 31/05/11 28/02/11 30/11/10 30/08/10 31/05/10 25/02/10 -
Price 5.25 7.11 6.30 5.44 5.67 5.34 5.09 -
P/RPS 0.89 1.24 0.91 0.77 0.81 0.77 0.76 11.06%
P/EPS 34.06 22.34 9.26 7.01 7.31 7.78 7.63 170.37%
EY 2.94 4.48 10.80 14.27 13.68 12.85 13.10 -62.96%
DY 0.70 2.76 3.82 4.78 4.59 3.57 3.75 -67.23%
P/NAPS 0.95 1.34 1.26 0.91 0.95 0.82 0.81 11.18%
Price Multiplier on Announcement Date
31/08/11 31/05/11 28/02/11 30/11/10 31/08/10 31/05/10 28/02/10 CAGR
Date 28/10/11 21/07/11 21/04/11 19/01/11 28/10/10 14/07/10 20/04/10 -
Price 5.86 6.52 6.03 6.49 5.68 5.51 5.44 -
P/RPS 0.99 1.14 0.87 0.91 0.81 0.80 0.81 14.27%
P/EPS 38.02 20.49 8.86 8.36 7.33 8.03 8.16 178.18%
EY 2.63 4.88 11.28 11.96 13.65 12.45 12.26 -64.06%
DY 0.63 3.01 3.99 4.01 4.58 3.46 3.51 -68.08%
P/NAPS 1.06 1.23 1.21 1.08 0.95 0.84 0.86 14.91%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment